Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

This study integrated 5 United States healthcare claims databases to evaluate the risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients who initiated apixaban vs. warfarin, stratified by obesity. Obese and morbidly obese patients were identified based on diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Alexander, Sah, Janvi, Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827069/
https://www.ncbi.nlm.nih.gov/pubmed/33429844
http://dx.doi.org/10.3390/jcm10020200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827069/
https://www.ncbi.nlm.nih.gov/pubmed/33429844
http://dx.doi.org/10.3390/jcm10020200

Ejemplares similares